Lan Pham

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

Jiayu Chen, Zijun Y. Xu‐Monette, Lijuan Deng et al. · Oncotarget · 2015 · 80 citations · Full text

Disease Progression, Immunology, Pathology +16

The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.

Simona Gatto, Barbara Scappini, Lan Pham et al. · PubMed · 2003 · 77 citations

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

Leo Yu Zhang, Krystle Nomie, Hui Zhang et al. · Clinical Cancer Research · 2017 · 63 citations · Full text

Roles for negative cell regulator 14-3-3σ in control of MDM2 activities

Yang Hy, Wen Yy, Lan Pham et al. · Oncogene · 2007 · 55 citations

Molecular Pharmacology, Signal Transduction, Cell Regulation +12

Brain injury results in lower levels of melatonin receptors subtypes MT1 and MT2

Nicole Danielle Osier, Lan Pham, Bunny J. Pugh et al. · Neuroscience Letters · 2017 · 30 citations · Full text

Melatonin Receptors, Neurophysiology, Medicine +12